BVS

Bioventus Stock Analysis

AI Rating

Good
  • Quality3/10
  • Growth 8/10
  • Value 4/10
Bioventus sales and earnings growth
BVS Growth
Good
  • Revenue Y/Y 0.04%
  • EPS Y/Y 182.69%
  • FCF Y/Y 320.54%
Bioventus gross and profit margin trends
BVS Profitability
Neutral
  • Gross margin 68.70%
  • EPS margin 4.90%
  • ROIC 5Y -4.88%
Bioventus net debt vs free cash flow
BVS Risk
Good
  • Debt / Equity 1.2
  • Debt / FCF 2.3
  • Interest coverage 2.2

Bioventus stock is less volatile than the overall market, so it's low risk. We give it a Good risk rating.

↗ More Medical Devices stocks